Tom brings 20+ years’ experience and expertise in Phase 1-3 pharmaceutical research. At Certara, he develops and executes SAPs, advises on clinical trial design and simulation, and consults on data-driven decision making for pharmaceutical and biotech clients globally. He’s proficient across a range of trial designs and analyses including bioequivalence, crossover, non-inferiority and cluster randomized designs.